Lloyd Price

NOVEMBER 25, 2023

This is due to a number of factors, including: The increasing prevalence of chronic diseases The rising cost of healthcare The increasing demand for patient-centered care As a result, DTx companies are still expected to be attractive targets for M&A deals. The average deal size for DTx M&A deals is increasing. Subscribe Today!

Pharmaceuticals 64

Pharmaceuticals Pain management Chronic pain management Mental health 64

Lloyd Price

FEBRUARY 18, 2024

Traditional healthcare players: Hospitals, insurers, and pharmaceutical companies are increasingly acquiring healthtech startups to improve efficiency, patient engagement, and data-driven decision making. Expand their digital health offerings. Subscribe Today! Gain access to new technologies and data assets. Subscribe Today!

Pharmaceuticals 61

Pharmaceuticals healthcare technology Digital Health Remote care 61

Healthcare IT News - Telehealth

MAY 6, 2020

Biofourmis’ digital therapeutics are used for RPM across three primary healthcare stakeholder groups: health systems, payers and pharmaceutical companies. Typically, the health systems and payers work together in a value-based care arrangement that involves shared risk and reward. Spry Health. Vivify Health.

Connected Health 188

Connected Health Telehealth Pharmaceuticals EHR 188

Healthcare IT Today

MARCH 28, 2024

While our first big push into remote care was a leap into the unknown, this time we want to make sure that we are surveying the landscape to make this a safe, smart, and financially responsible decision. So let’s take a moment to pause and evaluate healthcare at home to see where we are and where we need to go.

Primary Care 111

Primary Care Digital Health Telemedicine Mental health 111